MedApp S.A. (WSE:MDA)

MedApp Statistics

Total Valuation

MedApp has a market cap or net worth of PLN 40.65 million. The enterprise value is 45.23 million.

Market Cap	40.65M
Enterprise Value	45.23M

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

MedApp has 250.13 million shares outstanding.

Current Share Class	250.13M
Shares Outstanding	250.13M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	120.53M

Valuation Ratios

The trailing PE ratio is 29.33.

PE Ratio	29.33
Forward PE	n/a
PS Ratio	6.81
PB Ratio	1.48
P/TBV Ratio	n/a
P/FCF Ratio	26.45
P/OCF Ratio	7.94
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.65, with an EV/FCF ratio of 29.43.

EV / Earnings	31.83
EV / Sales	7.57
EV / EBITDA	12.65
EV / EBIT	25.21
EV / FCF	29.43

Financial Position

The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.07.

Current Ratio	1.04
Quick Ratio	0.30
Debt / Equity	0.07
Debt / EBITDA	0.54
Debt / FCF	1.25
Interest Coverage	16.16

Financial Efficiency

Return on equity (ROE) is 5.47% and return on invested capital (ROIC) is 3.81%.

Return on Equity (ROE)	5.47%
Return on Assets (ROA)	2.94%
Return on Invested Capital (ROIC)	3.81%
Return on Capital Employed (ROCE)	6.29%
Revenue Per Employee	746,500
Profits Per Employee	177,625
Employee Count	32
Asset Turnover	0.16
Inventory Turnover	0.30

Taxes

In the past 12 months, MedApp has paid 223,000 in taxes.

Income Tax	223,000
Effective Tax Rate	13.20%

Stock Price Statistics

The stock price has decreased by -15.14% in the last 52 weeks. The beta is 0.53, so MedApp's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	-15.14%
50-Day Moving Average	0.17
200-Day Moving Average	0.17
Relative Strength Index (RSI)	48.97
Average Volume (20 Days)	113,081

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedApp had revenue of PLN 5.97 million and earned 1.42 million in profits. Earnings per share was 0.01.

Revenue	5.97M
Gross Profit	3.59M
Operating Income	1.79M
Pretax Income	1.69M
Net Income	1.42M
EBITDA	3.58M
EBIT	1.79M
Earnings Per Share (EPS)	0.01

Balance Sheet

The company has 130,000 in cash and 1.93 million in debt, giving a net cash position of -1.80 million or -0.01 per share.

Cash & Cash Equivalents	130,000
Total Debt	1.93M
Net Cash	-1.80M
Net Cash Per Share	-0.01
Equity (Book Value)	27.56M
Book Value Per Share	0.10
Working Capital	414,000

Cash Flow

In the last 12 months, operating cash flow was 5.12 million and capital expenditures -3.58 million, giving a free cash flow of 1.54 million.

Operating Cash Flow	5.12M
Capital Expenditures	-3.58M
Free Cash Flow	1.54M
FCF Per Share	0.01

Margins

Gross margin is 60.11%, with operating and profit margins of 30.04% and 23.79%.

Gross Margin	60.11%
Operating Margin	30.04%
Pretax Margin	28.28%
Profit Margin	23.79%
EBITDA Margin	59.88%
EBIT Margin	30.04%
FCF Margin	25.74%

Dividends & Yields

MedApp does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	3.50%
FCF Yield	3.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MedApp has an Altman Z-Score of 2.54 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.54
Piotroski F-Score	5